Literature DB >> 25987958

Lean diabetes mellitus: An emerging entity in the era of obesity.

Amrutha Mary George1, Amith George Jacob1, Leon Fogelfeld1.   

Abstract

Much has been published on the characteristics of type 2 diabetes mellitus and its association with the epidemic of obesity. But relatively little is known about the incidence of lean diabetes, progression of disease and fate of the patients with low-normal body mass index (< 25). Studies in developing countries have shown that the clinical characteristics of these patients include history of childhood malnutrition, poor socioeconomic status, relatively early age of onset and absence of ketosis on withdrawal of insulin. In the United States, recent studies showed that the lean, normal weight diabetes is not rare especially among minority populations. They showed that these patients are mainly males, have higher prevalence of insulin use indicating rapid beta cell failure. They might have increased total, cardiovascular and non cardiovascular mortality when compared to obese diabetic patients. In this review, the epidemiologic and clinical features of lean diabetes are presented. The potential causal mechanisms of this emerging diabetes type that may include genetic, autoimmune, acquired and behavioral factors are discussed. The need for studies to further elucidate the causation as well as specific prevention and treatment of lean diabetes is emphasized.

Entities:  

Keywords:  Beta cell failure; Ketosis resistant diabetes of young; Lean diabetes; Obesity paradox; Sarcopenic obesity

Year:  2015        PMID: 25987958      PMCID: PMC4434081          DOI: 10.4239/wjd.v6.i4.613

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  52 in total

1.  Beyond the obesity paradox in diabetes: fitness, fatness, and mortality.

Authors:  Hermes Florez; Sumaya Castillo-Florez
Journal:  JAMA       Date:  2012-08-08       Impact factor: 56.272

2.  Clinical profile of lean NIDDM in South India.

Authors:  V Mohan; R Vijayaprabha; M Rema; G Premalatha; S Poongothai; R Deepa; E Bhatia; I R Mackay; P Zimmet
Journal:  Diabetes Res Clin Pract       Date:  1997-11       Impact factor: 5.602

3.  Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight.

Authors:  Christine B Jensen; Heidi Storgaard; Flemming Dela; Jens Juul Holst; Sten Madsbad; Allan A Vaag
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

4.  Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight.

Authors:  T S Hermann; C Rask-Madsen; N Ihlemann; H Domínguez; C B Jensen; H Storgaard; A A Vaag; L Kober; C Torp-Pedersen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 5.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

6.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

7.  Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual.

Authors:  Marie-Pierre St-Onge; Ian Janssen; Steven B Heymsfield
Journal:  Diabetes Care       Date:  2004-09       Impact factor: 19.112

8.  Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.

Authors:  Alexandra E Butler; Juliette Janson; Walter C Soeller; Peter C Butler
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

9.  Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

Authors:  S S Lund; L Tarnow; C D A Stehouwer; C G Schalkwijk; M Frandsen; U M Smidt; O Pedersen; H-H Parving; A Vaag
Journal:  Diabetes Obes Metab       Date:  2007-05       Impact factor: 6.577

10.  Exocrine pancreatic and beta-cell function in malnutrition-related diabetes among north Indians.

Authors:  E Bhatia; S S Baijal; K R Kumar; G Choudhuri
Journal:  Diabetes Care       Date:  1995-08       Impact factor: 19.112

View more
  44 in total

1.  Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.

Authors:  Tito Borner; Jayme L Workinger; Ian C Tinsley; Samantha M Fortin; Lauren M Stein; Oleg G Chepurny; George G Holz; Aleksandra J Wierzba; Dorota Gryko; Ebba Nexø; Evan D Shaulson; Ankur Bamezai; Valentina A Rodriguez Da Silva; Bart C De Jonghe; Matthew R Hayes; Robert P Doyle
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis.

Authors:  Hsiao-Wen Chang; Yi-Hwei Li; Chang-Hsun Hsieh; Pang-Yen Liu; Gen-Min Lin
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

3.  A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.

Authors:  Elizabeth G Mietlicki-Baase; Claudia G Liberini; Jayme L Workinger; Ron L Bonaccorso; Tito Borner; David J Reiner; Kieran Koch-Laskowski; Lauren E McGrath; Rinzin Lhamo; Lauren M Stein; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle; Matthew R Hayes
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

Review 4.  Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists.

Authors:  Josh Reed; Venkateswarlu Kanamarlapudi; Stephen Bain
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

5.  Novel lean type 2 diabetic rat model using gestational low-protein programming.

Authors:  Chellakkan S Blesson; Amy K Schutt; Meena P Balakrishnan; Robia G Pautler; Steen E Pedersen; Poonam Sarkar; Daniel Gonzales; Gang Zhu; Juan C Marini; Shaji K Chacko; Uma Yallampalli; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2016-02-10       Impact factor: 8.661

Review 6.  Highlighting Diabetes Mellitus: The Epidemic Continues.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01       Impact factor: 8.311

Review 7.  Review of Pharmacokinetic Data of Different Drug Classes in Goto-Kakizaki Rats, a Non-obese Model for Type 2 Diabetes Mellitus: Case Studies and Perspectives.

Authors:  Harilal Patel; Poonam Giri; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

8.  Physical Fitness but Not Diet Quality Distinguishes Lean and Normal Weight Obese Adults.

Authors:  Moriah P Bellissimo; Erika L Bettermann; Phong H Tran; Benjamin H Crain; Erin P Ferranti; Jose N Binongo; Terryl J Hartman; Dean P Jones; Thomas R Ziegler; Jessica A Alvarez
Journal:  J Acad Nutr Diet       Date:  2020-10-01       Impact factor: 4.910

Review 9.  The Obesity Paradox in Type 2 Diabetes and Mortality.

Authors:  Deirdre K Tobias; JoAnn E Manson
Journal:  Am J Lifestyle Med       Date:  2016-05-19

10.  Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.

Authors:  Alexander R Pinto; Rebecca H Ritchie; Charles D Cohen; Miles J De Blasio; Man K S Lee; Gabriella E Farrugia; Darnel Prakoso; Crisdion Krstevski; Minh Deo; Daniel G Donner; Helen Kiriazis; Michelle C Flynn; Taylah L Gaynor; Andrew J Murphy; Grant R Drummond
Journal:  Cardiovasc Diabetol       Date:  2021-06-01       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.